
Finding follow-up care and emotional support.
Finding follow-up care and emotional support.
Serving as a caregiver for a loved one going through a CLL diagnosis and treatment while utilizing resources to take care of oneself.
A list of helpful resources to assist people with CLL and their families cope with the emotional and practical aspects of the disease.
Imbruvica (ibrutinib) may be superior to standard of care in elderly patients with untreated chronic lymphocytic leukemia (CLL), according to phase 3 findings published in the New England Journal of Medicine.
Ian W. Flinn, M.D., Ph.D., discusses the use of Copiktra, which was approved in September for patients with relapsed/refractory chronic lymphocytic leukemia.
The Food and Drug Administration approved Imbruvica plus Gazyva for treatment-naïve patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
An acute promyelocytic leukemia survivor reflects on fear, courage and the future.
Toronto’s Jeff Lipton, PhD, MD, FRCPC, shares his thoughts on the outlook for blood cancers.
In an interview with CURE, Filippo Milano, M.D., Ph.D., explains what cord blood transplantation is and why it is important for patients to learn more.
Brian Koffman is a family physician who used his own CLL diagnosis to start a group that informs other patients and their loved ones.
The Food and Drug Administration (FDA) approved Sprycel (dasatinib) plus chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia